[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100470499":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":7,"responsibleParty":23,"collaborators":25,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":34,"eligibilityCriteria":35,"healthyVolunteers":30,"sex":36,"minAge":37,"maxAge":7,"enrollmentInfo":38,"targetDuration":41,"studyType":42,"phases":7,"briefSummary":43,"conditions":44,"keywords":46,"overallStatus":50,"whyStopped":7,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":7},{"fullName":5,"class":6},"Universidade do Porto","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"José Luis Fougo, MD, PhD","Centro de Mama - Centro Hospitalar Universitário de São João","STUDY_DIRECTOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Diana Gonçalves, MD, PhDc","CONTACT","(+351) 913017481","diana.goncalves@chsj.min-saude.pt",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Janete Santos, PhD","(+351) 225 513 600","investigaclinica@med.up.pt",{"type":24,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[26],{"name":27,"class":6},"Centro Hospitalar De São João, E.P.E.","100470499","registry-of-local-recurrences-after-breast-conserving-surgery-100470499",false,"NCT05406661","Registry of Local Recurrences After Breast-conserving Surgery","Registry of Local Recurrences After Breast-conserving Surgery in Portugal and Spain","R_ReLoCC","Inclusion Criteria:\n\n1. Female patients\n2. Age \\> 18 years\n3. Patients who have previously undergone breast-conserving surgery as part of the treatment of invasive or non-invasive (in situ) breast cancer\n\n   1. and adjuvant breast RT: total (WBI) or partial (PBI)\n   2. without adjuvant radiotherapy to the breast\n4. Recent histological diagnosis of homolateral, invasive or non-invasive (in situ) breast carcinoma\n\nExclusion Criteria:\n\n1. Male\n2. Age \\\u003C 18 years\n3. Stage 4 at diagnosis\n4. Patients operated outside the participating Centers and for whom it is not possible to obtain complete information regarding the primary treatment\n5. History of other primary invasive malignant tumor (except non-melanoma skin carcinomas)\n6. Patients already treated for another local recurrence of breast carcinoma\n7. Absence of clinical follow-up and records in clinical process","FEMALE","18 Years",{"count":39,"type":40},3000,"ESTIMATED","5 Years","OBSERVATIONAL","The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain.\n\nThe comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.",[45],"Breast Cancer Recurrent",[47,48,49],"Breast cancer treatment","Local recurrences","Breast-conserving surgery","NOT_YET_RECRUITING","2023-10-18",{"date":53,"type":54},"2023-10-19","ACTUAL",{"date":56,"type":40},"2023-12-01",{"date":58,"type":40},"2026-12",{"name":5,"class":6}]